ICER Evokes Dusp1-P38 Pathway Enhancing Chemotherapy Sensitivity in Myeloid Leukemia

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-0886
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Immunologic Consequences of Chemotherapy for Acute Myeloid Leukemia

Journal of Pediatric Hematology/Oncology
Child HealthOncologyPediatricsHematologyPerinatology
2013English

Activation of FGFR1β Signaling Pathway Promotes Survival, Migration and Resistance to Chemotherapy in Acute Myeloid Leukemia Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Secondary Acute Myeloid Leukemia (sAML) Immediately After Intensive Chemotherapy of Acute Lymphoblastic Leukemia (ALL)

Journal of Leukemia
2013English

Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia

Clinical Hematology International
2019English

Enhancing Nrf2 Pathway by Disruption of Keap1 in Myeloid Leukocytes Protects Against Sepsis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2011English

Reprogramming Acute Myeloid Leukemia Into Sensitivity for Retinoic-Acid-Driven Differentiation

Experimental Hematology
Cancer ResearchGeneticsHematologyMolecular BiologyCell Biology
2017English

Combination Treatment of an IDH1 Inhibitor With Chemotherapy in IDH1 Mutant Acute Myeloid Leukemia

Annals of Hematology
MedicineHematology
2020English

Acute Myeloid Leukemia

JAMA - Journal of the American Medical Association
Medicine
2010English

Acute Myeloid Leukemia

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy